112 related articles for article (PubMed ID: 38290569)
1. Remimazolam attenuates inflammation and kidney fibrosis following folic acid injury.
Song J; Yu W; Chen S; Huang J; Zhou C; Liang H
Eur J Pharmacol; 2024 Mar; 966():176342. PubMed ID: 38290569
[TBL] [Abstract][Full Text] [Related]
2. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury.
Chen M; Wen X; Gao Y; Liu B; Zhong C; Nie J; Liang H
Int Immunopharmacol; 2021 Nov; 100():108142. PubMed ID: 34555644
[TBL] [Abstract][Full Text] [Related]
3. Genetic and pharmacological inhibition of fatty acid-binding protein 4 alleviated inflammation and early fibrosis after toxin induced kidney injury.
Li L; Tao S; Guo F; Liu J; Huang R; Tan Z; Zeng X; Ma L; Fu P
Int Immunopharmacol; 2021 Jul; 96():107760. PubMed ID: 33991998
[TBL] [Abstract][Full Text] [Related]
4. Jmjd3/IRF4 axis aggravates myeloid fibroblast activation and m2 macrophage to myofibroblast transition in renal fibrosis.
Liang H; Liu B; Gao Y; Nie J; Feng S; Yu W; Wen S; Su X
Front Immunol; 2022; 13():978262. PubMed ID: 36159833
[TBL] [Abstract][Full Text] [Related]
5. Natural killer T cell/IL-4 signaling promotes bone marrow-derived fibroblast activation and M2 macrophage-to-myofibroblast transition in renal fibrosis.
Liu B; Jiang J; Liang H; Xiao P; Lai X; Nie J; Yu W; Gao Y; Wen S
Int Immunopharmacol; 2021 Sep; 98():107907. PubMed ID: 34243040
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological inhibition of SETD7 by PFI-2 attenuates renal fibrosis following folic acid and obstruction injury.
Liu B; Nie J; Liang H; Liang Z; Huang J; Yu W; Wen S
Eur J Pharmacol; 2021 Jun; 901():174097. PubMed ID: 33848540
[TBL] [Abstract][Full Text] [Related]
7. CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C
Deng X; Yang Q; Wang Y; Zhou C; Guo Y; Hu Z; Liao W; Xu G; Zeng R
Int Immunopharmacol; 2020 Nov; 88():106854. PubMed ID: 32771945
[TBL] [Abstract][Full Text] [Related]
8. Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-α involvement.
Comella F; Lama A; Pirozzi C; Annunziata C; Piegari G; Sodano F; Melini S; Paciello O; Lago Paz F; Meli R; Mattace Raso G
Biomed Pharmacother; 2024 Feb; 171():116094. PubMed ID: 38183745
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived Ly6C
Yang Q; Wang Y; Pei G; Deng X; Jiang H; Wu J; Zhou C; Guo Y; Yao Y; Zeng R; Xu G
Cell Death Dis; 2019 Mar; 10(4):291. PubMed ID: 30926787
[TBL] [Abstract][Full Text] [Related]
10. CU06-1004 alleviates oxidative stress and inflammation on folic acid-induced acute kidney injury in mice.
Bae CR; Kim Y; Kwon YG
J Pharmacol Sci; 2024 Feb; 154(2):77-85. PubMed ID: 38246731
[TBL] [Abstract][Full Text] [Related]
11. Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury.
Moonen L; Geryl H; D'Haese PC; Vervaet BA
BMC Nephrol; 2018 Dec; 19(1):343. PubMed ID: 30509215
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with Roxadustat (FG-4592) Attenuates Folic Acid-Induced Kidney Injury through Antiferroptosis via Akt/GSK-3
Li X; Zou Y; Xing J; Fu YY; Wang KY; Wan PZ; Zhai XY
Oxid Med Cell Longev; 2020; 2020():6286984. PubMed ID: 32051732
[TBL] [Abstract][Full Text] [Related]
13. STAT6 Deficiency Attenuates Myeloid Fibroblast Activation and Macrophage Polarization in Experimental Folic Acid Nephropathy.
Jiao B; An C; Du H; Tran M; Wang P; Zhou D; Wang Y
Cells; 2021 Nov; 10(11):. PubMed ID: 34831280
[TBL] [Abstract][Full Text] [Related]
14. One dose of cyclosporine A is protective at initiation of folic acid-induced acute kidney injury in mice.
Wen X; Peng Z; Li Y; Wang H; Bishop JV; Chedwick LR; Singbartl K; Kellum JA
Nephrol Dial Transplant; 2012 Aug; 27(8):3100-9. PubMed ID: 22294776
[TBL] [Abstract][Full Text] [Related]
15. Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 inhibition of macrophages.
Fang H; Zhang Y; Wang J; Li L; An S; Huang Q; Chen Z; Yang H; Wu J; Zeng Z
Int Immunopharmacol; 2021 Dec; 101(Pt B):108331. PubMed ID: 34810122
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis.
Zeng H; Gao Y; Yu W; Liu J; Zhong C; Su X; Wen S; Liang H
Front Pharmacol; 2022; 13():940716. PubMed ID: 35924048
[TBL] [Abstract][Full Text] [Related]
17. TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment.
Abdelmageed MM; Kefaloyianni E; Arthanarisami A; Komaru Y; Atkinson JJ; Herrlich A
Nephrol Dial Transplant; 2023 May; 38(5):1139-1150. PubMed ID: 36269313
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of IL-18 reduces renal fibrosis after ischemia-reperfusion.
Liang H; Xu F; Zhang T; Huang J; Guan Q; Wang H; Huang Q
Biomed Pharmacother; 2018 Oct; 106():879-889. PubMed ID: 30119258
[TBL] [Abstract][Full Text] [Related]
19. The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis.
Liang H; Zhang Z; Yan J; Wang Y; Hu Z; Mitch WE; Wang Y
Kidney Int; 2017 Dec; 92(6):1433-1443. PubMed ID: 28739140
[TBL] [Abstract][Full Text] [Related]
20. JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA/salt-induced hypertension.
Gao Y; Yu W; Song J; Nie J; Cui Z; Wen S; Liu B; Liang H
Hypertens Res; 2023 Aug; 46(8):1934-1948. PubMed ID: 37248323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
